Biovie
BIVI1.3302.92% ( -0.040 )
Biovie (BIVI)
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disea...
- Open
- 1.360
- High
- 1.401
- Low
- 1.310
- Prev. Close
- 1.370
- Volume
- 106.21K
- Turnover
- 144.25K
- Avg Price
- 1.358
- Bid/Ask Ratio
- --
- Amplitude
- 6.64%
- 52wk High
- 7.749
- Volume Ratio
- 0.60
- Turnover Ratio
- 1.42%
Biovie Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$5.25295.11%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 20 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Price Alert · Jul 14 at 06:02 AM
Pre-market hot trades in US stocks: Biovie up 9.01% in pre-market; Accenture down 3.29% in pre-market
- benzinga_article · Jul 13 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga_article · Jun 22 at 01:09 PM
BioVie shares are trading higher after the company filed a prospectus for a $300 million mixed securities shelf.
- prnewswire · Jun 5 at 02:32 PM
15:31 ETDid BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Price Alert · Jun 3 at 05:02 AM
Pre-market hot trades in US stocks: Biovie pre-market down 10.65%; T1 Energy pre-market down 8.72%
